ESPR Stock Falls After Esperion’s Mixed Q4 — Retail Remains Unfazed, Eyes ‘Massive’ Upcoming Catalysts Esperion reported earnings per share of $0.22 on revenue of $168.5 million, while Wall Street expected an EPS of $0.28 on revenue of $164.7 million.
ZVRA Stock Soars On Upbeat Q4 Results, Optimism For EMA Approval Of Niemann-Pick Disease Treatment For the fourth quarter, Zevra announced net revenue of $34.1 million, exceeding an analyst estimate of $28.05 million.
IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ImmunityBio stated that the application includes additional information requested by the FDA to support its supplemental BLA for papillary disease.
Small-Caps Shine as "Magnificent Seven" Lose Luster in 2026 Market Pivot In the first quarter of 2026, the financial markets have undergone a definitive "regime change" that many analysts are calling the "Great Convergence." After years of an increasingly narrow market led by a handful of mega-cap technology giants, the tide has finally turned. The iShares Russell 2000 ETF (
NYSE: IWM )
Webull Stock Continues Decline After Q4 Earnings Miss – What Does The Street Think? Rosenblatt lowered the firm's price target on Webull to $12 from $15 and kept a ‘Buy’ rating on the shares, per TheFly.
Webull Stock Falls As Q4 Profit Miss Disappoints Traders The company posted net income per ordinary share of $0.01 that was below Wall Street estimates of $0.05 per share as per data from Fiscal.ai.
Vanda Now Looks To Public Hearing For Hetlioz In Jet Lag Disorder After Multiple FDA Rejections According to Vanda, the FDA has not granted such a hearing in the context of drug approvals for potentially over 40 years.
Better iShares ETF: Large-Cap Exposure with IVV or Small-Cap Focused IWM Compare how cost, sector focus, and risk profiles set IVV and IWM apart for investors seeking different equity exposures.
Is IWM or SPY the Better ETF for Investors? Here's What the Data Says Expense ratios, sector weights, and portfolio breadth set these two ETFs apart.
Small Cap Stock Plug Power Rallies, Retail Cheers Q4 Earnings, New CEO Appointment The company said that Jose Luis Crespo will assume the role of Chief Executive Officer effective March 2, 2026.
Why Did NTLA Stock Jump 10% In Pre-Market Today? The company announced that the U.S. FDA lifted a clinical hold on its Phase 3 trial of ATTR-CM treatment drug.
Hawaiian Electric Shares Are Higher Today – Know Why The company said that its fourth quarter 2025 net income was $40 million, or $0.23 per share, compared to a net loss of $68 million, or $0.40 per share in 2024.
SLS Stokes Retail Anticipation For Breakout Rally — What’s Driving The Interest? SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid Leukemia who have achieved complete remission following second-line salvage therapy.
